• Content (Accesskey 0)
  • Navigation (Accesskey 1)
  • About us
  • Events
  • How to contact us
  • What's new
  • Accessibility
  • Legal notice
  • Privacy notice
DeutschEnglish
BASG
menu
  • Market Surveillance
    Official announcements
    • Messages in brief
    • Human medicines
    • Veterinary medicines
    • Blood & tissue
    • Medical devices
    • Illegal market
    Public registers
    • Medicine shortages catalogue open_in_new
    • Catalogue according to the regulation on ensuring the provision of medicinal products open_in_new
    • Austrian Medicinal Product Index open_in_new
    • Pharmaceutical companies
    • Register of retailers
    • Internet pharmacies open_in_new
    • BASG official announcement open_in_new
    • BASG voting results open_in_new
    Reporting
    • Human adverse reaction notification
    • Veterinary Adverse Event Reports
    • Quality defects
    • Medicine shortages
    • Illegal occurrences
    • Medical devices vigilance
    • Haemovigilance
    • Tissue vigilance
    • MedSafety Week 2022
  • For Consumers
    Facts worth knowing about medicines
    • Medicinal products
    • Vaccines
    • Administration of medicines
    • Package leaflet
    • Prescription/Non-prescription requirements
    • Ability to drive
    • Medication allergies
    • Doping
    • Expiry date and storage of medicines
    • Disposal of medicinal products
    • Useful Links
    Clinical Trials
    • Clinical studies and the war in Ukraine
    • EUPATI
    • Austrian information center regarding clinical trials for cancer therapy
    Medicines from the Internet
    • Online medicine retailers
    • Illegal websites
    Illegal market
    • Enforcement
    • Falsified medicines
    • "Predatory publishers" and their effect
    • Glossary
    Medical devices
  • For Healthcare Professionals
    Safety information (DHPC)
    Clinical trials
    • Clinical trials of medicinal products - REG (EU) 536/2014
    • Clinical trials with medicinal products - DIR 2001/20/EC
    • Good Clinical Practice
    • Non-Interventional-Studies NIS
    • Compassionate use/Named Patient Use
    • Clinical investigations with medical devices
    • Clinical studies and COVID-19
    • Clinical trials and the war in Ukraine
    Blood safety
    • Authorisation and inspection of blood establishments
    Tissue safety
    • Certification, authorisation, and inspection of tissue establishments
    Medical Device Operators
    • FAQ's medical device operators
    Bringing into circulation
    • Dispensing of veterinary antibiotics
    • Internet pharmacy
    • Self-assessment of pharmacies
    • Sampling
    Austrian Pharmacopoeia
    • Draft monographs for comments
    • Archive of monographs
    • Archive of deleted monographs
    CHMP Meeting Highlights-BASG
    • The CHMP introduces itself
  • For Companies
    Online services
    • Login online services open_in_new
    • Reporting adverse reactions open_in_new
    • Registration online services open_in_new
    • Contact
    • Veterinary Antimicrobial Consumption
    • Data provision medicine shortages
    • Data provision Falsified Medicines Directive
    • FAQ online Service
    • PHAROS user group
    • Instructions for use
    Marketing authorisation & life-cycle
    • Marketing authorisation procedure
    • Austria as RMS
    • Electronic application
    • AGES eValidator
    • FAQ electronic Submission
    • Life-Cycle
    • Commission decisions
    • Forms for medicinal products
    • Change of ownership acc. to Art 25 AMG
    • Veterinary medicinal products
    • FAQ marketing authorisation & life-cycle
    Pharmacovigilance
    • Pharmacovigilance inspection
    • PHV-wordings
    • Submission of Periodic Safety Update Reports (PSURs)
    • FAQ pharmacovigilance
    • Guideline pharmacovigilance
    Medicinal products
    • Scientific advice by BASG
    • Quality of medicines
    • Medicines for children
    • Plasma derived products
    • Batch release
    • Recombinant proteins
    • Controlled substances
    • Radiopharmaceuticals
    Import and export of medicines
    • Import of medicines
    • FAQ Import of medicinal products
    • Certificate for a Pharmaceutical Product (CPP)
    Medical devices
    • COVID 19
    • Manufacturer and representative
    • Importer and distributor
    • Medical devices fee
    • Free Sale Certificate - (FSC)
    • MDR / IVDR
    Authorisation and certification
    • GMP/ GDP
    • Good Laboratory Practice (GLP)
    • IT inspections
    Borderline products
    • Decisions of the AGBR
  1. Home
  2. About us
  3. BASG publications
  4. BASG approval procedure
  5. BASG Protocols
  • About us
  • Vision, values and strategy
  • Activities
  • Legal basis
  • BASG publications
    • BASG approval procedure
      • BASG Protocols
    • BASG announcements
    • Rules of Procedure (in German only)
  • Fees
  • Quality Management
  • European Network
  • Scientific Board
  • Statistics
  • Publications
  • Official electronic signature
  • Press

BASG Protocols

Email

Further inquiry note

basg@basg.gv.at
Page last modified: 27/08/2014

For Companies

  • Marketing authorisation & Life-Cycle
  • Medical devices
  • Pharmacovigilance

Market Surveillance

  • Medicine shortage
  • Quality defects

For Healthcare Professionals

  • Safety information (DHPC)
  • Austrian Pharmacopoeia
  • Clinical trials

For Consumers

  • Medicinal products
  • Clinical trials
  • Medicines from the Internet
© 2023 Bundesamt für Sicherheit im Gesundheitswesen
  • Sitemap
keyboard_arrow_up to top

Navigation

close
  • Market Surveillance »
    • Zurück
    • Market Surveillance
    • Official announcements »
      • Zurück
      • Official announcements
      • Messages in brief
      • Human medicines
      • Veterinary medicines
      • Blood & tissue
      • Medical devices
      • Illegal market
    • Public registers »
      • Zurück
      • Public registers
      • Medicine shortages catalogue
        open_in_new
      • Catalogue according to the regulation on ensuring the provision of medicinal products
        open_in_new
      • Austrian Medicinal Product Index
        open_in_new
      • Pharmaceutical companies
      • Register of retailers
      • Internet pharmacies
        open_in_new
      • BASG official announcement
        open_in_new
      • BASG voting results
        open_in_new
    • Reporting »
      • Zurück
      • Reporting
      • Human adverse reaction notification
      • Veterinary Adverse Event Reports »
        • Zurück
        • Veterinary Adverse Event Reports
        • FAQ adverse events veterinary
      • Quality defects
      • Medicine shortages
      • Illegal occurrences
      • Medical devices vigilance
      • Haemovigilance
      • Tissue vigilance
      • MedSafety Week 2022
  • For Consumers »
    • Zurück
    • For Consumers
    • Facts worth knowing about medicines »
      • Zurück
      • Facts worth knowing about medicines
      • Medicinal products »
        • Zurück
        • Medicinal products
        • Classification guide for cell and tissue products
        • Generics
        • Biosimilars
        • Herbal medicinal products
        • Veterinary medicinal products
      • Vaccines »
        • Zurück
        • Vaccines
        • FAQ Vaccines
      • Administration of medicines
      • Package leaflet »
        • Zurück
        • Package leaflet
        • Black triangle
        • Visually impaired patients
        • Off Label Use
      • Prescription/Non-prescription requirements
      • Ability to drive
      • Medication allergies
      • Doping
      • Expiry date and storage of medicines
      • Disposal of medicinal products
      • Useful Links
    • Clinical Trials »
      • Zurück
      • Clinical Trials
      • Clinical studies and the war in Ukraine
      • EUPATI
      • Austrian information center regarding clinical trials for cancer therapy
    • Medicines from the Internet »
      • Zurück
      • Medicines from the Internet
      • Online medicine retailers »
        • Zurück
        • Online medicine retailers
        • FAQs - internet pharmacies
      • Illegal websites
    • Illegal market »
      • Zurück
      • Illegal market
      • Enforcement
      • Falsified medicines
      • "Predatory publishers" and their effect
      • Glossary
    • Medical devices
  • For Healthcare Professionals »
    • Zurück
    • For Healthcare Professionals
    • Safety information (DHPC)
    • Clinical trials »
      • Zurück
      • Clinical trials
      • Clinical trials of medicinal products - REG (EU) 536/2014 »
        • Zurück
        • Clinical trials of medicinal products - REG (EU) 536/2014
        • National rules and regulations
        • Recommendations for preparation for Reg (EU) 536/2014
      • Clinical trials with medicinal products - DIR 2001/20/EC »
        • Zurück
        • Clinical trials with medicinal products - DIR 2001/20/EC
        • Pharmacovigilance for Clinical Trials with Medicinal Products
        • EU Clinical Trials Register
      • Good Clinical Practice »
        • Zurück
        • Good Clinical Practice
        • FAQ - Documentation (GCP)
        • FAQ - Regulatory Requirements (GCP)
        • FAQ - Import of Investigational Medicinal Products
        • FAQ - Identification of Investigational Medicinal Products
        • FAQ - Handling of Investigational Medicinal Products
        • FAQ - Addictive substances as investigational drugs
      • Non-Interventional-Studies NIS
      • Compassionate use/Named Patient Use
      • Clinical investigations with medical devices »
        • Zurück
        • Clinical investigations with medical devices
        • Procedures for Clinical Trials after the Brexit
      • Clinical studies and COVID-19 »
        • Zurück
        • Clinical studies and COVID-19
        • FAQ - COVID-19 studies
      • Clinical trials and the war in Ukraine
    • Blood safety »
      • Zurück
      • Blood safety
      • Authorisation and inspection of blood establishments
    • Tissue safety »
      • Zurück
      • Tissue safety
      • Certification, authorisation, and inspection of tissue establishments
    • Medical Device Operators »
      • Zurück
      • Medical Device Operators
      • FAQ's medical device operators
    • Bringing into circulation »
      • Zurück
      • Bringing into circulation
      • Dispensing of veterinary antibiotics
      • Internet pharmacy
      • Self-assessment of pharmacies
      • Sampling
    • Austrian Pharmacopoeia »
      • Zurück
      • Austrian Pharmacopoeia
      • Draft monographs for comments
      • Archive of monographs
      • Archive of deleted monographs
    • CHMP Meeting Highlights-BASG »
      • Zurück
      • CHMP Meeting Highlights-BASG
      • The CHMP introduces itself
  • For Companies »
    • Zurück
    • For Companies
    • Online services »
      • Zurück
      • Online services
      • Login online services
        open_in_new
      • Reporting adverse reactions
        open_in_new
      • Registration online services
        open_in_new
      • Contact
      • Veterinary Antimicrobial Consumption »
        • Zurück
        • Veterinary Antimicrobial Consumption
        • Provision of data
        • Extension DDDVet, DCDVet
        • FAQ antibiotics flow
      • Data provision medicine shortages
      • Data provision Falsified Medicines Directive
      • FAQ online Service »
        • Zurück
        • FAQ online Service
        • FAQ Registration
        • FAQ User rights
        • FAQ online services
        • FAQ Notification medicine shortages
      • PHAROS user group
      • Instructions for use »
        • Zurück
        • Instructions for use
        • System requirements for electronic submission
    • Marketing authorisation & life-cycle »
      • Zurück
      • Marketing authorisation & life-cycle
      • Marketing authorisation procedure »
        • Zurück
        • Marketing authorisation procedure
        • Central Authorisation
        • MRP/DCP authorisation »
          • Zurück
          • MRP/DCP authorisation
          • Conditional Authorisation
          • Letter of Authorisation
          • MRP/DCP - national translations
          • Withdrawal during the authorisation procedure
        • National Authorisation
        • Line Extension
        • Utilisation of genetic resources and traditional knowledge associated with genetic resources
        • Parallel import
        • Accessible patient information leaflet
        • Safety features AMVS
        • Classification and supply of substances under control »
          • Zurück
          • Classification and supply of substances under control
          • Prescription of medicines
      • Austria as RMS »
        • Zurück
        • Austria as RMS
        • DCP/MRP/RUP/SRP Slots
        • RMS transfer
        • RMS NEWS
      • Electronic application
      • AGES eValidator
      • FAQ electronic Submission
      • Life-Cycle
      • Commission decisions
      • Forms for medicinal products »
        • Zurück
        • Forms for medicinal products
        • National authorisation Life-Cycle forms
      • Change of ownership acc. to Art 25 AMG
      • Veterinary medicinal products »
        • Zurück
        • Veterinary medicinal products
        • Austria as RMS
          open_in_new
        • The new EU veterinary medicinal products (VMP) regulation »
          • Zurück
          • The new EU veterinary medicinal products (VMP) regulation
          • European guidelines
          • Application for Marketing Authorisation and Variations
          • Implementation of new QRD templates
          • SPC harmonisation
          • Clinical trials
          • Pharmacovigilance
          • Union Product Database (UPD) »
            • Zurück
            • Union Product Database (UPD)
            • Nomenclature of the texts
            • Organisation Management Service (OMS)
          • Implementation status in Austria
        • Antimicrobial Consumption
          open_in_new
        • Contact
      • FAQ marketing authorisation & life-cycle »
        • Zurück
        • FAQ marketing authorisation & life-cycle
        • Application for variation »
          • Zurück
          • Application for variation
          • Variations to MRP and DCP authorisations
          • Variations to national authorisations
          • Approval Letter following Variation
          • End of Procedure date in case of Type IA/IAin Variations
        • Art. 5(3) referral on nitrosamines in human medicinal products
        • Austrian Medicinal Product Index
        • ASMF
        • Decisions - electronic delivery
        • Braille writing system
        • Batch release
        • Anti-doping warning
        • Elemental Impurities - ICHQ3D
        • Environmental Risk Assessment - ERA
        • SmPC and PL
        • Accessible patient information leaflet
        • Homeopathic Medicinal Products
        • Annual fee
        • Medicines for children/Paediatric Worksharing
        • Mock-ups
        • Naming of medicinal products
        • Parallelimport
        • Herbal Medicinal Products
        • Black Triangle
        • Sunset clause
        • Renewal of marketing authorisation
        • Distributor in Austria
        • Authorisation/registration applications
    • Pharmacovigilance »
      • Zurück
      • Pharmacovigilance
      • Pharmacovigilance inspection
      • PHV-wordings
      • Submission of Periodic Safety Update Reports (PSURs)
      • FAQ pharmacovigilance
      • Guideline pharmacovigilance
    • Medicinal products »
      • Zurück
      • Medicinal products
      • Scientific advice by BASG
      • Quality of medicines
      • Medicines for children
      • Plasma derived products
      • Batch release
      • Recombinant proteins
      • Controlled substances »
        • Zurück
        • Controlled substances
        • Forms
        • FAQ Suchtmittel
      • Radiopharmaceuticals
    • Import and export of medicines »
      • Zurück
      • Import and export of medicines
      • Import of medicines
      • FAQ Import of medicinal products
      • Certificate for a Pharmaceutical Product (CPP)
    • Medical devices »
      • Zurück
      • Medical devices
      • COVID 19
      • Manufacturer and representative
      • Importer and distributor
      • Medical devices fee
      • Free Sale Certificate - (FSC)
      • MDR / IVDR
    • Authorisation and certification »
      • Zurück
      • Authorisation and certification
      • GMP/ GDP »
        • Zurück
        • GMP/ GDP
        • FAQ - GMP/GDP
        • FAQ - reportable qualified persons
        • FAQ - human plasma for fractionation
        • FAQ - enforcement
      • Good Laboratory Practice (GLP) »
        • Zurück
        • Good Laboratory Practice (GLP)
        • FAQ - GLP
      • IT inspections »
        • Zurück
        • IT inspections
        • FAQ - CAS
    • Borderline products »
      • Zurück
      • Borderline products
      • Decisions of the AGBR
  • About us »
    • Zurück
    • About us
    • Vision, values and strategy
    • Activities
    • Legal basis »
      • Zurück
      • Legal basis
      • Legal ordinances of BASG
    • BASG publications »
      • Zurück
      • BASG publications
      • BASG approval procedure »
        • Zurück
        • BASG approval procedure
        • BASG Protocols
      • BASG announcements
      • Rules of Procedure (in German only)
    • Fees »
      • Zurück
      • Fees
      • Official announcements
    • Quality Management
    • European Network
    • Scientific Board
    • Statistics »
      • Zurück
      • Statistics
      • Reports COVID-19 Vaccination
      • Statistics on reporting
    • Publications »
      • Zurück
      • Publications
      • Annual Reports
      • Folder
      • Scientific Publications
    • Official electronic signature
    • Press »
      • Zurück
      • Press
      • Photos
  • Events
    open_in_new
  • How to contact us
  • What's new »
    • Zurück
    • What's new
    • Registration and cancellation
    • RSS
  • Accessibility »
    • Zurück
    • Accessibility
    • Accessibility of the online form for reporting of suspected adverse reactions (vaccines/medicines)
  • Legal notice
  • Privacy notice

This website uses cookies

We use cookies to adapt the website to your needs and to offer special features to you. By using our website, you agree to it.

Further information on cookies can be found in our privacy policy.

Your data protection settings

Enable and disable individual cookies. Required cookies cannot be disabled.

Required Cookies

  • Cookie settings supi
  • Session Load Balancer SESSIONID

Marketing & Analytics

  • Matomo MATOMO_SESSID, _pk_ses, _pk_id